ANTINUCLEAR ANTIBODIES IN PATIENTS TAKING L1

被引：17

作者：

BERDOUKAS, V

机构：

来源：

LANCET | 1991年 / 337卷 / 8742期

关键词：

D O I：

10.1016/0140-6736(91)92483-I

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：672 / 672

页数：1

共 8 条

[1] SEVERE CARDIOVASCULAR ADVERSE-EFFECTS IN ASSOCIATION WITH ACUTE, HIGH-DOSE CORTICOSTEROID ADMINISTRATION [J].

ERSTAD, BL .

DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (12) :1019-1023

[2] SUDDEN-DEATH AFTER TREATMENT WITH PULSED METHYLPREDNISOLONE [J].

GARDINER, PVG ;

GRIFFITHS, ID .

BRITISH MEDICAL JOURNAL, 1990, 300 (6717) :125-125

[3] LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) [J].

KONTOGHIORGHES, GJ ;

BARTLETT, AN ;

HOFFBRAND, AV ;

GODDARD, JG ;

SHEPPARD, L ;

BARR, J ;

NORTEY, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) :295-300

[4]

MEHTA, 1991, LANCET, V337, P298

[5] COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS [J].

OLIVIERI, NF ;

KOREN, G ;

HERMANN, C ;

BENTUR, Y ;

CHUNG, D ;

KLEIN, J ;

STLOUIS, P ;

FREEDMAN, MH ;

MCCLELLAND, RA ;

TEMPLETON, DM .

LANCET, 1990, 336 (8726) :1275-1279

[6]

Porter J B, 1989, Baillieres Clin Haematol, V2, P459, DOI 10.1016/S0950-3536(89)80027-7

[7]

TONDURY P, 1990, BRIT J HAEMATOL, V76, P550

[8] PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR [J].

WOLFE, L ;

OLIVIERI, N ;

SALLAN, D ;

COLAN, S ;

ROSE, V ;

PROPPER, R ;

FREEDMAN, MH ;

NATHAN, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1600-1603

← 1 →